Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Vaginal Candidiasis

Conditions

Vaginal Candidiasis, Bacterial Vaginosis, Trichomonal Vaginitis

Trial Timeline

Oct 1, 2010 → Apr 1, 2015

About Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)

Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276) is a pre-clinical stage product being developed by Bayer for Vaginal Candidiasis. The current trial status is completed. This product is registered under clinical trial identifier NCT01335373. Target conditions include Vaginal Candidiasis, Bacterial Vaginosis, Trichomonal Vaginitis.

Hype Score Breakdown

Clinical
5
Activity
2
Company
7
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT01335373Pre-clinicalCompleted